Efficacy and Safety of the YUKON Drug Eluting Stent in Diffuse Coronary Artery Disease

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 606 participants.

Also called NCT01418794

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 606 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT01418794
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
Not reported
Countries
China (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT01418794. Randomized; double masking; primary purpose treatment. Start 2010-10 (registry gives no type); primary completion 2011-11 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Efficacy and Safety of the YUKON Drug Eluting Stent in Diffuse Coronary Artery Disease
Condition
Acute Coronary Syndromes
Intervention (Device)
High dose rapamycin stent
Intervention (Device)
Low dose rapamycin stent
Lead sponsor
Shenyang Northern Hospital (class: other)

Record details

Record id
cardio:ct-nct01418794
Content hash
5ca8705f64fe94b86a8aeccb3b53f873717ac2b8a346b57f644af27f33cd2a28